Pipeline Framework: Syringes Needles and Associated Products

A pipeline has been launched for Syringes Needles and Associated ProductsThe contract start Date is 03 January 2021. Approach to market date is 20 January 2020Syringes and needles products, including hypodermic needles, insulin needles, biopsy needles, hypodermic syringes, tuberculin syringes, insulin syringes, prefilled syringes, catheter tip syringes, combined needle and syringe products, spinal needles and kits (including NRFit), epidural needles and kits (including NRFit), nerve block/nerve stimulation needles (including NRFit), speciality needles, intraosseous needles and devices, blunt fill drawing up devices, oral drug syringes and syringe caps – all with or without safety devices where appropriate. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 40 000 000 GBP to 60 000 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated value over the maximum 4 year Framework Agreement will be in the region of 240 000 000 GBP.This is a potential opportunity from the government, and the pipeline gives advance notice of an opportunity that might be offered by the public sector in the future – allowing potential suppliers to plan accordingly. When a public sector organisation publishes a pipeline notice, it does not necessarily mean that an opportunity will be offered in the future.For more information contact: DHL Supply Chain Limited acting on behalf of Supply Chain Coordination Ltd acting as agent of the NHS Business Services Authority, c/o Skipton House, 80 London Road, London SE1 6LH. Emailabigail.ballard@supplychain.nhs.uk